Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. This randomized controlled trial uses a three-group design.

Our specific aims are to: (1) Determine the impact of a Patient Activation and Education intervention with and without physician activation and teledermatology on skin cancer early detection practices, (2) Determine the impact of the intervention on time to diagnosis, and (3) Estimate the cost and cost-effectiveness of the intervention as a secondary outcome.


Clinical Trial Description

There are currently more than 420,000 Americans who are long-term survivors of childhood and adolescent cancer. While these groups have greatly benefited from recent medical advances, primarily increasing overall survival rates, treatment advances have come at a cost. It is now clear that childhood radiation therapy has caused survivors to be at extremely high risk for non-melanoma skin cancer (NMSC) and increased risk of melanoma. Early detection is crucial to reduce the morbidity caused by NMSCs and the morbidity and mortality incurred due to melanoma. Both patient and provider action are needed to detect and treat early skin cancers and to find new solutions to ensure expedited follow-up care and treatment, especially among those who live where they have little access to dermatologists.

The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. All participants will receive text messages encouraging them to examine their skin and request physician examinations while concurrently driving them to a study website that provides education related to the associated skills, and reinforces and expands the text messages. To reduce skin cancers among this young and dispersed patient population, this study will address several key issues: (1) how to provide patients with the skills needed to conduct effective skin self-examinations; 2) how to prompt action from patient's physicians when worrisome moles and lesions are found; and 3) how to ensure rapid access to dermatologic exams, which in some parts of the US can take weeks or months to schedule. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02046811
Study type Interventional
Source Harvard School of Public Health
Contact
Status Completed
Phase N/A
Start date March 2015
Completion date January 1, 2018

See also
  Status Clinical Trial Phase
Completed NCT00027586 - Imatinib Mesylate in Treating Patients With Metastatic Melanoma Phase 2
Not yet recruiting NCT02230462 - Patient Satisfaction After Facial Reconstruction N/A
Terminated NCT02900248 - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Completed NCT00224744 - Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage Phase 3
Completed NCT03132012 - Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection N/A
Terminated NCT00865878 - ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients Phase 2
Not yet recruiting NCT05359419 - Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities Phase 4
Active, not recruiting NCT00001813 - Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Completed NCT02147080 - A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults N/A
Completed NCT00007631 - Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer Phase 3
Completed NCT00847912 - CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial Phase 4
Recruiting NCT02836548 - HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma Phase 1/Phase 2
Completed NCT01482104 - New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) N/A
Enrolling by invitation NCT04630886 - Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery Early Phase 1
Completed NCT03012581 - Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types Phase 2
Withdrawn NCT02813902 - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors Phase 1
Not yet recruiting NCT02408835 - Negative Pressure Wound Therapy in Groin Dissection N/A
Completed NCT00204789 - Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients Phase 2
Completed NCT02310503 - Spanish Registry of Mohs Surgery
Active, not recruiting NCT04267861 - M7824 Related Adverse Effects in Adults With Cancer